ATLANTA, Dec. 18, 2025 /PRNewswire/ -- Huxley Medical, Inc. announced the SANSA® home sleep apnea test has received regulatory clearance from the United States Food and Drug Administration (FDA) to be ...

Less than two months after smashing its own (unofficial) record in power density with its proprietary axial flux motor, YASA has unveiled a real-world application of the technology as an in-wheel ...

Clearance marks a pivotal step in bringing to market the world’s first benchtop analyzer capable of running chemistries, immunoassays, and hematology in a single device Truvian Health (“Truvian”) ...

Currently, scientists struggle to forecast volcano eruption events, as no universally reliable, real-time eruption forecasting framework is available. Instead, researchers often rely on retrospective ...

insights from industryStephan Botzki & Ian McEnteggartSenior Applications Engineer - Composites Market ManagerInstron In this interview, industry experts Stephan Botzki and Ian McEnteggart, senior ...

Axial Therapeutics has stepped back into the spotlight, emerging after almost two years of silence with a new name, focus and financing. Two years ago, the biotech was closing in on data from a phase ...

The National Drug Law Enforcement Agency (NDLEA) has launched a digital platform that will make its drug integrity test and visa clearance processes seamless, more accessible and ultimately curb the ...

Please provide your email address to receive an email when new articles are posted on . The p-Tau181 test is the first to be cleared for use in a primary care setting. Blood-based biomarker tests ...

A new blood test could speed up diagnosis and treatment for people dealing with early memory or thinking changes. The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to ...

Switzerland-based Roche this week said it has received U.S. regulatory clearance for an Alzheimer’s blood test. This test is used in primary care offices for a patient’s initial assessment of ...

Roche, which currently has investigational Alzheimer’s disease drug trontinemab in phase 3 trials, has secured FDA clearance of its blood-based biomarker test for the condition. The minimally invasive ...

This AF430S motor from Turntide Technologies answers a call for electrification in components in industrial equipment and performance vehicles. The lightweight axial flux motor delivers up to 96% ...